Pharmstandard, Lung Biotechnology and Posco celebrated exits as the organ transportation system developer went public in a $91m offering.
TransMedics, a US-based medical device producer backed by pharmaceutical firm Pharmstandard International and steel conglomerate Posco, went public yesterday in a $91m initial public offering.
The company issued 5.69 million shares priced at $16.00 each on the Nasdaq Global Market, achieving a market cap of $430m. Its shares had risen to $22.49 by yesterday’s close, on their first day of trading.
Founded in 1998, TransMedics has developed a device called the Organ Care System (OCS), which uses warm blood…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
